Skip to content

Effects of yoga on anxiety, stress, sleep quality, and fatigue in women with first diagnosis of breast cancer - a randomized controlled trial

Effects of yoga on anxiety, stress, sleep quality, and fatigue in women with first diagnosis of breast cancer - a randomized controlled trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
DRKS
Registry ID
DRKS00031593
Enrollment
40
Registered
2023-03-31
Start date
2023-04-10
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

C50

Interventions

Group 1: 8 yoga sessions in a group setting for 90 min (once per week) Group 2: Wait list control group without yoga intervention for 8 weeks
after 8 weeks, patients in the control group undergo the yoga intervention (8 yoga sessions in a group setting for 90 min once per week).

Sponsors

Hochschule für angewandte Wissenschaften Coburg
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Women with first diagnosis of breast cancer; no more than five years since diagnosis; self-reported presence of anxiety, sleep disturbances, and/or fatigue; sufficiently good general health to participate in the intervention (assessed by the treating physician); sufficient knowledge of German language to answer the questionnaires and follow the lessons; written informed consent for study participation and data collection.

Exclusion criteria

Exclusion criteria: Diagnosis more than five years ago; regular yoga/meditation practice or relaxation exercises at least twice per month; metastatic breast cancer.

Design outcomes

Primary

MeasureTime frame
Group difference in change in anxiety (anxiety subscale of the DASS (depression anxiety stress scales) questionnaire) from baseline to post-intervention

Secondary

MeasureTime frame
Group differences in changes in depression (DASS-depression subscale), stress (DASS-stress subscale, PSS-10), sleep quality (PSQI), fatigue (FACIT-F), quality of life (FACT-G), and self-efficacy (CBI) from baseline to 8 weeks. All parameters are re-evaluated after 16 weeks (post-intervention measurement for wait-list control group, follow-up measurement for intervention group). In addition, treatment expectations are assessed at baseline (TEX-Q).

Countries

Germany

Contacts

Public ContactJana Kraft

Hochschule für angewandte Wissenschaften Coburg

jana.kraft@hs-coburg.de095613178124

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026